Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: A randomized controlled trial

JAMA

Volumn 281, Issue 14, 1999, Pages 1282-1290

  Strawford, Alison ^b   Barbieri, Theresa ^b   Van Loan, Marta ^b   Parks, Elizabeth ^b   Catlin, Don ^b   Barton, Norman ^b   Neese, Richard ^b   Christiansen, Mark ^b   King, Janet ^b   Hellerstein, Marc K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; OXANDROLONE; PLACEBO;

ADULT; AIDS RELATED COMPLEX; ANDROGEN THERAPY; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; MALE; MUSCLE STRENGTH; NITROGEN BALANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SUBSTITUTION THERAPY; WASTING SYNDROME; WEIGHT REDUCTION;

EID: 0033553201     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.14.1282     Document Type: Article

References (42)

1. Kotler DP, Tierney A, Wang J, et al. Magnitude of body cell mass depletion and timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
2. Suttman U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected out-patients. J AIDS Hum Retrovirol. 1995;8:239-246.
3. Kotler DP, Tierney A, Culpepper-Morgan J, et al. Effect of home total patenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr. 1990;14:454-458.
4. Hoh R, Pelfini A, Neese RA, et al. De novo lipogenesis predicts short-term body composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting. Am J Clin Nutr. 1998;68:154-163.
5. Von Roenn JH, Armstrong D, Kotler DP, et al. Megestrol acetate in patients with AIDS related cachexia. Ann Intern Med. 1994;121:393-399.
6. Oster MH, Enders SH, Samuels ST, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994;121:400-408.
7. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance due to HIV protease inhibitors. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 2-5, 1998; Chicago, III. Abstract 410:156.
8. Hengel RL, Geary JAM, Vuchetich MA, et al. Multiple symmetrical lipomatosis associated with protease inhibitor therapy. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 2-5,1998; Chicago, III. Abstract 407:156.
9. Roth VR, Angel JB, Kravcik S, et al. Development of cervical fat pad following treatment with HIV-1 protease. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, February 2-5, 1998, Chicago, III. Abstract 411:157.
10. Silva M, Skolnick P, Gorbach S, et al. Effects of protease inhibitors on weight and body composition in HIV-infected patients. AIDS. In press.
11. Dobs AS, Dempsey MA, Landenson PW, et al. Endocrine disorders in men infected with HIV. Am J Med. 1988;84:611-616.
12. Hellerstein MK, Grunfeld C, Wu K, et al. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;76:559-565.
13. Mulligan K, Grunfeld C, Hellerstein MK, et al. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;77:956-962.
14. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med. 1996;125: 873-882.
15. Strawford A, Van Loan M, King J, Hellerstein M. Effects of nandrolone decanoate on nitrogen balance, lean body mass, metabolic abnormalities and performance in borderline hypogonadal men with HIV-associated weight loss. J AIDS Hum Retrovirol. 1998; 20:137-147.
16. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1998;129:18-26.
17. Hellerstein MK. Nutritional and endocrine consequences of HIV infection. In: Crowe S, Hoy J, Mills J, eds. Management of the HIV-Infected Patient. New York, NY: Cambridge University Press; 1996:194-205.
18. Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335:1-7.
19. Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis. Hepatology. 1993;17:564-576.
20. Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 1984;311:1464-1470.
21. Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG. The effects of oxandrolone on the growth hormone and gonadal axis in boys with constitutional delay of growth and puberty. Clin Endocrinol. 1993;38:393-398.
22. World Health Organization. Energy and Protein Requirements: Report of a Joint FAO/WHO/UNU Expert Consultation. Geneva, Switzerland: World Health Organization; 1985. Technical Report Service 724; 206.
23. Kraemer WJ, Fry AC. Strength testing: development and evaluation of methodology. In: Maud PJ, Foster C, eds. Physiological Assessment of Human Fitness: Human Kinetics. Champaign, III: Human Kinetics; 1995:115-137.
24. Berner DL, Brown J. Protein nitrogen combustion method collaborative study 1: comparison of total Kjeldahl nitrogen and combustion results. J Am Oil Chem Soc. 1994;71:1291-1293.
25. Cook JGH. Factors influencing the assay of creatinine. Ann Clin Biochem. 1975;12:219.
26. Hellerstein MK, Christiansen M, Kaempfer S, et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest. 1991;87: 1841-1852.
27. Hellerstein MK, Neese R. Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol. 1992; 263(5 pt 1):E988-E1001.
28. Hellerstein MK, Schwarz JM, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr. 1996;16:523-557.
29. Catlin DH, Kammerer RC, Hatton CK, et al. Analytical chemistry at the games of the XXIIIrd Olympiad in Los Angeles. Clin Chem. 1987;33:319-327.
30. Catlin DH, Hatton CK, Starcevic SH. Issues in detecting abuse of anabolic steroids and testosterone by analysis of athletes' urine. Clin Chem. 1997;43:1280-1288.
31. Forbes GB. Human Body Composition; Growth, Aging, Nutrition and Activity. New York, NY: Springer-Verlag NY Inc; 1987:64-71.
32. Catlin DH. Anabolic steroids. In: DeGroot L, ed. Endocrinology. 3rd ed. Orlando, Fla: WB Saunders; 1995:2362-2376.
33. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions, summary of Expert Conference Sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr. 1997;66:683-706.
34. Fujioka M, Shinohara Y, Baba S, et al. Pharmacokinetic properties of testosterone propionate in normal men. J Clin Endocrinol Metab. 1986;63:1361-1364.
35. Nindl B, Friedl K, Frykman P, et al. Physiologic recovery after severe weight loss [abstract]. FASEB J. 1994;8:A724.
36. Fruth SJ, Worrell TW. Factors associated with menstrual irregularities and decreased bone mineral density in female athletes. J Orthop Sports Phys Ther. 1995; 22:26-38.
37. Tvede N, Kaplan G, Halkjaer-Kristensen J, et al. The effect of light, moderate and severe bicycle exercise on lymphocyte subsets, natural and lymphokine activated killer cells, lymphocyte proliferative response and interleukin-2 production. Int J Sports Med. 1993;14:275-282.
38. Cannon JG, Fielding RA, Fiatarone MA, et al. Increased interleukin 1b in human skeletal muscle after exercise. Am J Physiol. 1989;257 (2 pt 2):R451-R455.
39. Evans WJ, Cannon JG. The metabolic effects of exercise-induced muscle damage. Exerc Sport Sci Rev. 1991;19:99-125.
40. Appelbaum DM, Haffner S, Hazzard WR. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein-2 cholesterol. Metabolism. 1987;36:945-952.
41. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson R. Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med. 1989; 86:27-31.
42. Wheeler DA, Muurahainen N, Launer C, Gilbert C, Bartsch G. Change in body weight (wt) as a predictor of death and opportunistic (OC) in HIV by history of prior OC. In: Program and abstracts of the 11th International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia. Abstract Tu.B 2383: 332.